<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05057559</url>
  </required_header>
  <id_info>
    <org_study_id>CON-OA-002</org_study_id>
    <nct_id>NCT05057559</nct_id>
  </id_info>
  <brief_title>Observational Clinical Investigation of Arthrosamid in Knee Osteoarthritis</brief_title>
  <acronym>LUNA</acronym>
  <official_title>Prospective, Observational, Open-label, Clinical Investigation of Intra-articular Arthrosamid® Injection in Subjects With Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Contura</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Contura</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, long-term, observational, all-comers, open-label, multi-centre&#xD;
      clinical investigation enrolling subjects with knee osteoarthritis who is eligible for&#xD;
      treatment with Arthrosamid® according to the Instruction for Use.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adverse events</measure>
    <time_frame>5 years</time_frame>
    <description>The total number of treatment emergent adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WOMAC pain subscale</measure>
    <time_frame>6, 12, 24, 36, 48 and 60 months</time_frame>
    <description>change from baseline in WOMAC (WOMAC Osteoarthritis Index) pain subscale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC stiffness subscale</measure>
    <time_frame>6, 12, 24, 36, 48 and 60 months</time_frame>
    <description>change from baseline in WOMAC (WOMAC Osteoarthritis Index) stiffness subscale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC physical function subscale</measure>
    <time_frame>6, 12, 24, 36, 48 and 60 months</time_frame>
    <description>change from baseline in WOMAC (WOMAC Osteoarthritis Index) physical function subscale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's global assessment of impact of osteoarthritis</measure>
    <time_frame>6, 12, 24, 36, 48 and 60 months</time_frame>
    <description>An eleven point, numeric rating scale (0-10) where 0 =&quot; No impact&quot; and 10 = &quot;Worst imaginable impact&quot;</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited from participating rheumatology or orthopedic centers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Stated willingness to comply with all study procedures and availability for the&#xD;
             duration of the study&#xD;
&#xD;
          -  Male or female, aged ≥ 18 years&#xD;
&#xD;
          -  Clinical diagnosis of knee OA&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  If an active skin disease or infection is present at or near the injection site&#xD;
&#xD;
          -  If the joint is infected or severely inflamed&#xD;
&#xD;
          -  If a degradable intra-articular injectable such as hyaluronic acid is present, it must&#xD;
             be expected to be absorbed according to manufacturer's information for the specific&#xD;
             product, before injection with Arthrosamid®&#xD;
&#xD;
          -  If the patient has previously received treatment with a different non-absorbable&#xD;
             injectable/implant&#xD;
&#xD;
          -  If the patient has received a knee alloplasty or has any foreign material in the knee&#xD;
&#xD;
          -  If the patient has undergone knee arthroscopy within the last 6 months&#xD;
&#xD;
          -  If the patient has haemophilia or is in uncontrolled anticoagulant treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jeff Craven</last_name>
    <phone>+45 81 10 09 00</phone>
    <email>jcr@contura.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Parker Institute</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 16, 2021</study_first_submitted>
  <study_first_submitted_qc>September 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

